HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Trist Selected Research

GSK876008

5/2009Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Trist Research Topics

Disease

1Major Depressive Disorder (Major Depressive Disorders)
12/2011
1Shock
05/2009

Drug/Important Bio-Agent (IBA)

1casopitantIBA
12/2011
1GSK876008IBA
05/2009